£220M NHS Suit Over Drug Patent Heads To Supreme Court
By Christopher Crosby · June 8, 2020, 7:44 PM BST
The U.K.'s top court on Monday agreed to hear the National Health Service's £220 million ($280 million) lawsuit against an international pharmaceutical company accused of blocking sales of a generic drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login